A Singular Vision

Singular Vision

Relentless pursuit of transformative therapies targeting FcRn, a central mediator in autoimmune responses.

Focused Execution

Focused Execution

Rapid clinical advancement across multiple indications for our lead investigational candidate SYNT001.

Vast Reach

Vast Reach

FcRn plays a central role across a wide swath of autoimmune diseases affecting millions of people worldwide.

Syntimmune Employees in a Meeting

NEWS & PROGRESS

JULY 9, 2018

Syntimmune strengthens leadership team with appointment of chief medical officer

LATEST TWEET

@syntimmune | JULY 19, 2018

Syntimmune’s founders and advisors are among the world’s most influential contributors to the field of FcRn biology… https://t.co/tB64vSuJYm